Effect of body mass index and cholesterol‐rich apolipoprotein‐B‐containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors‐based therapy: A retrospective analysis.

Saved in:
Bibliographic Details
Title: Effect of body mass index and cholesterol‐rich apolipoprotein‐B‐containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors‐based therapy: A retrospective analysis.
Authors: Hu, Zixin1,2 (AUTHOR), Zheng, Yumin2,3 (AUTHOR), Zheng, Jiabin2 (AUTHOR), Wang, Yan4 (AUTHOR), Liao, Jiangquan4 (AUTHOR), Liu, Zhening2,3 (AUTHOR), Li, Jia2,3 (AUTHOR), Cui, Huijuan2 (AUTHOR) cuihj1963@sina.com
Source: Cancer Medicine. Jun2024, Vol. 13 Issue 11, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.7241